PD-1/PD-L1抑制剂联合抗血管生成酪氨酸激酶抑制剂治疗复发或转移性鼻咽癌的疗效与安全性：系统评价与单臂荟萃分析

Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Anti-Angiogenic Tyrosine Kinase Inhibitors for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Systematic Review and Single-Arm Meta-Analysis.